AR-H040922 FREEBASE

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C28H33N5O3
Molecular Weight	487.5933
Optical Activity	( + )
Defined Stereocenters	2 / 2
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

C[C@@H](NC(=O)[C@@H](CCCNC(N)=N)NC(=O)C(C1=CC=CC=C1)C2=CC=CC=C2)C3=CC=C(O)C=C3

InChI

InChIKey=AOUQZUZEYSDMEZ-NTKDMRAZSA-N

InChI=1S/C28H33N5O3/c1-19(20-14-16-23(34)17-15-20)32-26(35)24(13-8-18-31-28(29)30)33-27(36)25(21-9-4-2-5-10-21)22-11-6-3-7-12-22/h2-7,9-12,14-17,19,24-25,34H,8,13,18H2,1H3,(H,32,35)(H,33,36)(H4,29,30,31)/t19-,24-/m1/s1

HIDE SMILES / InChI

Molecular Formula	C28H33N5O3
Molecular Weight	487.5933
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	2 / 2
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Sat Dec 16 11:14:59 GMT 2023` Edited by `admin` on `Sat Dec 16 11:14:59 GMT 2023`
Record UNII	7NCK567YKQ
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

AR-H040922 FREEBASE

Common Name

English

N-((1R)-4-((AMINOIMINOMETHYL)AMINO)-1-((((1R)-1-(4-HYDROXYPHENYL)ETHYL)AMINO)CARBONYL)BUTYL)-.ALPHA.-PHENYLBENZENEACETAMIDE

Systematic Name

English

Y1 RECEPTOR ANTAGONIST 1

Common Name

English

BENZENEACETAMIDE, N-((1R)-4-((AMINOIMINOMETHYL)AMINO)-1-((((1R)-1-(4-HYDROXYPHENYL)ETHYL)AMINO)CARBONYL)BUTYL)-.ALPHA.-PHENYL-

Systematic Name

English

(2R)-2-((2,2-DIPHENYLACETYL)AMINO)-5-GUANIDINO-N-((1R)-1-(4-HYDROXYPHENYL)ETHYL)PENTANAMIDE

Systematic Name

English

H-409/22

Common Name

English

Code System Code Type Description

CAS

221697-09-2

Created by admin on Sat Dec 16 11:14:59 GMT 2023 , Edited by admin on Sat Dec 16 11:14:59 GMT 2023

PRIMARY

PUBCHEM

5311439

Created by admin on Sat Dec 16 11:14:59 GMT 2023 , Edited by admin on Sat Dec 16 11:14:59 GMT 2023

PRIMARY

FDA UNII

7NCK567YKQ

Created by admin on Sat Dec 16 11:14:59 GMT 2023 , Edited by admin on Sat Dec 16 11:14:59 GMT 2023

PRIMARY

MANUFACTURER PRODUCT INFORMATION

AR-H040922(FREEBASE)

Created by admin on Sat Dec 16 11:14:59 GMT 2023 , Edited by admin on Sat Dec 16 11:14:59 GMT 2023

PRIMARY

Related Record Type Details


					7NCK567YKQ

AR-H040922 FREEBASE

ACTIVE MOIETY

Comments:

Administration of the high dose AR-H040922 attenuated systolic blood pressure by 6-11 mmHg (p<0.05) during and after exercise without affecting HR. None of the two doses of AR-H040922 influenced any of the ischaemic parameters or duration of exercise, however. The maximal increase in NPY was higher during AR-H040922 (p<0.05) compared with placebo.


					7NCK567YKQ

AR-H040922 FREEBASE

ACTIVE MOIETY

Comments:

Cardiovascular Diseases (Not Specified), CARDIOVASCULAR DRUGS, Neuropeptide Y1 (NPY Y1) Antagonists